The diagnosis of DILE is primarily clinical, supported by laboratory findings. A detailed patient history focusing on drug exposure is essential. The presence of ANAs, especially anti-histone antibodies, is a common serological finding in DILE. However, these antibodies are not exclusive to DILE and may be present in SLE as well. It is crucial to differentiate DILE from SLE, as management strategies differ significantly.
